MedTrace Logo

Effect of Magnesium Supplementation on Elevated Systolic Blood Pressure

NCT05690464 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2025-12-23

No results posted yet for this study

Summary

The purpose of this study is to assess whether 480 mg/day magnesium glycinate supplementation for 12 weeks lowers blood pressure.

Conditions

  • Blood Pressure

Interventions

DIETARY_SUPPLEMENT

magnesium glycinate supplement

magnesium glycinate (480 mg/day)

DIETARY_SUPPLEMENT

placebo

placebo

Sponsors & Collaborators

  • Pure Encapsulations

    collaborator INDUSTRY

  • Brigham and Women's Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
74 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-01-17
Primary Completion
2025-03-12
Completion
2026-05-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05690464 on ClinicalTrials.gov